Hence, our study which investigated the general applicability of the antigen-presentation regulator PSMB8 as a prognostic biomarker in pan-cancer from an immuno-oncological perspective, could provide a rational and theoretical foundation for future mechanism studies. This evidence concerns the gene PSMB8 and cancer.